Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu’s arteritis
Crossref DOI link: https://doi.org/10.1007/s00296-017-3847-6
Published Online: 2017-10-13
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sun, Ying
Ma, Lili
Ma, Lingying
Kong, Xiufang
Chen, Huiyong
Lv, Peng
Lin, Jiang
Liu, Hao
Yan, Yan
Ji, Zongfei
Yang, Chengde
Dai, Shengming
Wan, Weiguo
Zou, Yaohong
Jin, Xuejuan
Jiang, Lindi
License valid from 2017-10-13